James ML, Ross AC, Nicola T, Steele C, Ambalavanan N. VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice. Am J Physiol Lung Cell Mol Physiol 304: L803-L812, 2013. First published April 12, 2013 doi:10.1152/ajplung.00257.2012We have recently shown that a combination of vitamin A (VA) and retinoic acid (RA) in a 10:1 molar ratio (VARA) synergistically increases lung retinoid content in newborn rodents, more than either VA or RA alone in equimolar amounts. We hypothesized that the increase in lung retinoids would reduce oxidative stress and proinflammatory cytokines, resulting in attenuation of alveolar simplification and abnormal lung function in hyperoxia-exposed newborn mice. Newborn C57BL/6 mice were exposed to 85% O2 (hyperoxia) or air (normoxia) for 7 or 14 days from birth and given vehicle or VARA every other day. Lung retinol content was measured by HPLC, function was assessed by flexiVent, and development was evaluated by radial alveolar counts, mean linear intercept, and secondary septal crest density. Mediators of oxidative stress, inflammation, and alveolar development were evaluated in lung homogenates. We observed that VARA increased lung retinol stores and attenuated hyperoxia-induced alveolar simplification while increasing lung compliance and lowering resistance. VARA attenuated hyperoxiainduced increases in DNA damage and protein oxidation accompanied with a reduction in nuclear factor (erythroid-derived 2)-like 2 protein but did not alter malondialdehyde adducts, nitrotyrosine, or myeloperoxidase concentrations. Interferon-␥ and macrophage inflammatory protein-2␣ mRNA and protein increased with hyperoxia, and this increase was attenuated by VARA. Our study suggests that the VARA combination may be a potential therapeutic strategy in conditions characterized by VA deficiency and hyperoxia-induced lung injury during lung development, such as bronchopulmonary dysplasia in preterm infants. bronchopulmonary dysplasia; vitamin A; retinoic acid; 8-OH deoxyguanosine; nuclear factor (erythroid-derived 2)-like 2 protein; 10:1 molar combination of Vitamin A and all-trans retinoic acid BRONCHOPULMONARY DYSPLASIA (BPD) in preterm infants, a common cause of morbidity and mortality, is characterized by fewer and larger alveoli with loss of septation (alveolar simplification) and reduced microvascular development (2, 8, 15, 27) . The etiology of BPD is multifactorial and includes genetic predisposition, barotrauma, and volutrauma from mechanical ventilation, reactive oxygen species (ROS) production from prolonged oxygen use and high oxygen concentrations, and infections that lead to inflammation, damage, and attenuation of normal growth and repair of the developing neonatal lung (2).
infections that lead to inflammation, damage, and attenuation of normal growth and repair of the developing neonatal lung (2) .
Extremely low birth weight (ELBW; birth wt Յ1,000 g) infants are at high risk for the development of BPD (3) . Low plasma and tissue concentrations of vitamin A (VA; retinol) are often observed in ELBW infants and are associated with a higher incidence of BPD (43) . Randomized controlled trials and a recent systematic review indicate VA supplementation decreases BPD and/or death (18) , and trends for improvement have also been noted in longer-term outcomes at 18 -22 mo of age (6) . Despite supplementation, 25% of infants remain VA deficient (45) , and the mechanisms by which VA improves outcomes have not been determined. We have shown that a 10:1 molar combination of VA (the nutrient) and all-trans retinoic acid (RA; the metabolite) (labeled "VARA") improved tissue retinoid stores much more than either VA or RA alone at equimolar concentrations in neonatal rats and mice (26, 41) . However, it is important to determine whether such an increase in retinoid stores translates into an improvement in alveolar development and lung function during hyperoxia exposure. We hypothesized that VARA supplementation would attenuate hyperoxia-induced alveolar simplification and abnormal lung function by reducing oxidative stress and proinflammatory cytokines.
MATERIALS AND METHODS
All protocols were approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham. All experiments were done with a minimum of six mice from at least two litters for each condition.
Study groups. C57BL/6 dams and litters were exposed to either 85% O2 (hyperoxia) or air (normoxia) (26) . Dams were alternated every 24 h from hyperoxia to air to reduce oxygen toxicity. Newborn mice were orally administered vehicle (canola oil) or VARA (0.05 mmol VA:0.005 mmol RA/g dose) on alternate days (26, 41) .
On postnatal days 7 or 14, pups were anesthetized with ketamine/ xylazine, and pulmonary function was evaluated on a flexiVent (36, 37) . Mice were then killed, and lungs were either inflation-fixed for histology, or lung homogenates were prepared for RNA (5, 26, 36, 37) , protein analysis (5, 26, 36, 37) , and for markers of oxidative stress. Lung retinol was measured by HPLC (26, 41) . Alveolar septation in mice starts at ϳ4 days of age and is mostly complete by 14 days of age (13, 44) . The lung histology of mice exposed to hyperoxia from birth to postnatal day 7 do not exhibit the alveolar simplification seen at postnatal day 14 Analysis of alveolar morphometry. Lung alveolar morphometry was performed as previously described (5, 26, 36, 37) . Alveolar development was evaluated by radial alveolar counts (RAC) (16) , mean linear intercept (MLI) (35) , and secondary septal crest density (SSC) (26, 37) .
Analysis of markers of oxidative stress. Lung homogenates were analyzed for protein carbonyls, 3-nitrotyrosine, and malondialdehyde (MDA) adducts by ELISA (Cell Biolabs, San Diego, CA). Myeloperoxidase (MPO) was measured by colorimetric activity assay (BioVision, Mountain View, CA). DNA was isolated from whole lung using a Qiagen DNeasy Blood and Tissue kit (Qiagen, Valencia, CA) and analyzed for 8-OH deoxyguanosine (8-OHdG) by ELISA (Cell Biolabs). Nuclear and cytoplasmic extracts were isolated from whole lung using the Active Motif Nuclear Extract kit (Active Motif, Carlsbad, CA) and analyzed for nuclear factor (erythroid-derived 2)-like 2 protein (Nrf2) by ELISA (Active Motif).
Analysis of mRNA. Total RNA was isolated using a Qiagen total RNA isolation kit and then quantified and reverse transcribed with SYBR Green/Fluorescein Mastermix Reagents (Qiagen). Mouse Angiogenesis RT 2 Profiler PCR Arrays (PAMM-024; Qiagen) were used for the analysis of 84 angiogenic and proinflammatory genes on a Bio-Rad iCycler System (Table 1) . Normalization of gene expression values were to the average geometric mean of hypoxanthine guanine phosphoribosyl transferase 1, heat shock protein 90␣ class B member 1, and ␤-actin expression. Quantitative real-time PCR was performed with specific primers (Table 2) as previously described (5, 26, 36, 37) .
Western blot analysis. Newborn mouse lungs were homogenized in 1 ml of a tissue protein extraction reagent (Pierce Biotechnology, Rockford, IL) containing complete proteinase inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and centrifuged at 7,000 g for 5 min, and the supernatant was frozen at Ϫ80 0 C until analysis as described previously (5, 37) . Protein concentrations were measured using the Bio-Rad Bradford Protein Assay (Bio-Rad, Hercules, CA). Ten micrograms of protein per lane were fractionated by 10% TrisGlycine SDS-PAGE followed by transfer to a polyvinylidene difluoride membrane (Millipore, Billerica, MA). Western Blot analysis was done for platelet-derived growth factor (PDGF)-A (rabbit primary antibody at 1:200; Santa Cruz Biotechnology, Santa Cruz, CA), tenascin C (mouse monoclonal antibody at 1:1,000; Novus Biologicals, Littleton, CO), and ␤-tubulin (rabbit primary antibody at 1:4,000; Santa Cruz Biotechnology) overnight at 4°C. The secondary antibodies were a goat anti-rabbit (Sigma, St. Louis, MO) and a goat anti-mouse (Santa Cruz Biotechnology) used at 1:10,000 and 1:3,000 dilutions for 1 h at room temperature. Immunoreactive bands were visualized by treatment with Immun-Star Western blotting detection reagents (Bio-Rad) according to the manufacturer's instructions. Densitometry was done normalizing for ␤-tubulin, a protein that did not change significantly with hyperoxia in this model.
Analysis of cytokines. Lung homogenates were analyzed for 32 key mouse cytokines and chemokines using the Milliplex MAP mouse cytokine/chemokine Premixed 32 Plex (Millipore) on a Luminex 200 platform (Luminex, Austin, TX) ( Table 3 ). Samples were further analyzed for macrophage inflammatory protein-2␣ (MIP-2␣) and interferon-␥ (IFN-␥) by ELISA (R&D Systems; Qiagen).
Statistical analysis. Data were expressed as means ϩ SE. Data were analyzed by two-way ANOVA to test for separate and combined effects of VARA and hyperoxia. Multiple-comparison testing (Student-Newman-Keuls) was performed if statistical significance (P Ͻ 0.05) was noted by ANOVA.
RESULTS

Group characteristics.
The mouse pups exposed to hyperoxia did not have obvious respiratory distress or impaired survival, and administration of VARA was well tolerated, with survival Ͼ90% in all groups. No significant differences in growth were noted with hyperoxia or with retinoid administration at 7 or 14 days.
VARA increases lung retinol. VARA increased lung retinol in air-exposed mice (Fig. 1) . VARA also improved lung retinol in hyperoxia-exposed mice, although the magnitude of increase was less compared with that in air-exposed mice (Fig. 1) .
VARA attenuates hyperoxia-induced alveolar simplification. Hyperoxia-exposed mice receiving vehicle had alveolar simplification (reduced RAC, increased MLI, and decreased SSC) compared with the air-vehicle groups (Fig. 2) . VARA attenuated hyperoxia-induced alveolar simplification as evident by an increase in RAC, reduction in MLI, and an increase in SSC (Fig. 2) . Alveolar development in air-VARA mice was similar to that of air-vehicle mice.
VARA attenuates hyperoxia-induced alterations in lung function. Hyperoxia-vehicle mice had reduced lung compliance and increased lung resistance compared with air-vehicle mice (Fig. 3) . Hyperoxia-VARA mice had lung compliance and resistance similar to that of air-vehicle and air-VARA mice, indicating that VARA supplementation prevented the hyperoxia-induced reduction in lung compliance and the increase in resistance (Fig. 3) .
VARA attenuates hyperoxia-induced increases in mediators of oxidative stress. Hyperoxia increased 8-OHdG (Fig. 4A ), protein carbonyls ( Fig. 4B ), nuclear Nrf2 (Fig. 4E) , and MPO activity ( VARA attenuates hyperoxia-induced increases in the mRNA expression of key proinflammatory mediators. Hyperoxia-vehicle mice had increased mRNA expression of many proinflammatory and angiogenic genes such as neutrophil-activating protein-3 (Cxcl1), MIP-2␣ [Cxcl2; interleukin (IL)-8], epithelial-derived neutrophil-activating peptide 78 (Cxcl), epiregulin, frizzled homolog 5, hypoxia-inducible factor, 1␣-subunit (HIF-1␣), IFN-␥, IL-1␤, matrix metalloproteinase-9 (MMP-9), and tumor necrosis factor-␣ (TNF-␣), and the increased expression of these genes was prevented by VARA. Hyperoxia-vehicle mice had decreased mRNA expression of angiopoietin-2, fibroblast growth factor-1 (FGF-1), matrix metalloproteinase-2 (MMP-2), and vascular endothelial growth factor (VEGF) A, and these changes were prevented by VARA. During normoxia, VARA modulated the expression of many proinflammatory and angiogenic genes, with MIP-2␣ being the only gene whose expression was decreased fourfold (Table 1) .
VARA attenuates hyperoxia-induced increases in the protein expression of key proinflammatory mediators. Hyperoxia-vehicle mice had increased protein expression of many proinflammatory mediators. The protein concentrations of MIP-2␣ and IFN-␥ were increased by hyperoxia and reduced by VARA. VEGF was increased by hyperoxia, but VARA (compared with vehicle) did not alter VEGF concentrations during either normoxia or hyperoxia. During normoxia, VARA re- duced protein levels of eotaxin, IFN-␥-induced protein-10, and monokine induced by IFN-␥ (Table 3) . Effects on growth factors and extracellular matrix molecules known to be involved in lung development. Hyperoxia increased mRNA of PDGF-A and tenascin C regardless of the presence of VARA, compared with air-vehicle mice (Fig. 5) . The protein concentration of PDGF-A was slightly decreased by hyperoxia, whereas the protein concentration of tenascin C was increased by hyperoxia (Fig. 5) .
DISCUSSION
The present study is the first to determine the functional benefits of increased lung retinoids using the VARA combination on alveolar development and lung function in a newborn mouse model. We have previously shown that the VARA combination improved lung retinoid concentration more than either VA or RA alone in a 4-day acute lung injury model (26) . In the present study, we have shown that the increase in lung retinoids translates into reduced oxidative stress and an improvement in alveolar development and lung function during hyperoxia exposure. In addition, we have identified potential pathways that may be modulated by retinoids and lead to improvement of hyperoxia-induced impaired alveolar development and lung function.
There are multiple strengths to our study. We evaluated markers of oxidative stress, mRNA and protein expression of angiogenic factors, the protein expression of key cytokines and chemokines, and the mRNA expression of important growth factors and extracellular matrix proteins during a critical phase of alveolar septation during postnatal lung development. Lung structure and function were evaluated following exposure to normoxia as well as hyperoxia, in combination with VARA. However, our study has some limitations. We evaluated important mechanisms associated with abnormal alveolar development (oxidative stress, angiogenesis, cytokines, chemokines, growth factors, and extracellular matrix), but retinoids may affect multiple pathways simultaneously, including those that were not evaluated in this study (1, 17, 39, 47) . Experiments using whole lung homogenates do not permit the identification of changes in gene expression or protein synthesis in selected cell populations in vivo, such as airway epithelia, endothelial VARA, 10:1 molar combination of vitamin A (the nutrient) and all-trans retinoic acid (the metabolite); n ϭ 3 mice/group. Gene expression was normalized to the average geometric mean of the following housekeeping genes: hypoxanthine guanine phosphoribosyl transferase 1, heat shock protein 90␣ (cytosolic) class B member 1, and ␤-actin. Fold-change values greater than one indicate a positive or an upregulation, and the fold-regulation is equal to the fold-change. Fold-change values less than one indicate a negative or downregulation, and the fold-regulation is the negative inverse of the fold-change. *P Ͻ 0.05 vs. 21% O2 vehicle and #P Ͻ 0.05 vs. corresponding vehicle. Numbers in bold indicate fold changes in expression that are Ͼ4 with a P Ͻ 0.05. Lung development in the human from week 24 of gestation through the first two years of age parallels lung development of mice in the first two postnatal weeks (13, 44) , and the newborn mouse lung is therefore a good model for impaired alveolar development in preterm infants.
VA (retinol) is essential for normal lung morphogenesis and postnatal maturation (31) . Retinol is thought to be stored in lung lipid interstitial cells within the lung alveolar wall, which synthesize and secrete RA (20) . RA binds to retinoic acid receptors (RAR) (␣, ␤, or ␥) and heterodimerizes with retinoid X receptor at retinoic response elements to regulate the expression of many genes (32) . Transgenic animal models have shown that the deletion of ␣-and ␥-receptors decreases alveolar development (35) but the deletion of the ␤-receptor leads to premature septation, indicating its role in inhibiting the premature onset of alveolarization (34) . Chronic postnatal hyperoxia inhibits alveolar development in animals with postnatal alveolar septation (e.g., rats, mice) but not in animals with prenatal septation (e.g., sheep) (33) . Newborn mice exposed to chronic hyperoxia have enlarged air spaces and reduced alveolar development similar to the histopathology of BPD (38) . Veness-Meehan et al. (46) demonstrated that RA treatment of newborn rats improves survival and alveolarization during hyperoxia exposure. The exact mechanisms by which RA attenuates hyperoxia effects in the newborn lung are uncertain, but RA is known to modulate oxidative stress mediators (1, 24) , proinflammatory mediators (26) , and growth factor expression (39) , and such mechanisms may be involved in our model. Regardless of the mechanism by which retinoids exert their effect, an increase in lung VA is essential for this benefit. We have shown that a 10:1 molar combination of VARA, more so than equimolar amounts of VA or RA administered alone, increased lung VA in a short-term exposure of newborn mice to hyperoxia (26) . The present study determined that the VARA combination also improves impaired alveolar septation and lung function in hyperoxia-exposed newborn mice. We also observed that hyperoxia exposure reduces lung VARA levels. There are two possible explanations. One is that hyperoxia exposure leads to increased "consumption" or tissue In mouse pups given vehicle, alveolar size is larger in hyperoxia-exposed (B) compared with air-exposed (A) mice, indicating delay in septation. Administration of VARA moderately attenuated the hyperoxia-induced increase in alveolar size (D) and did not change alveoli of air-exposed animals (C). E-G: mean linear intercept (E), radial alveolar count (F), and secondary septal crest density (G) at 14 days of age in mouse pups given either vehicle or VARA while being exposed to air or hyperoxia (mean Ϯ SE; n ϭ 6 mice/group; *P Ͻ 0.05 vs. corresponding air; #P Ͻ 0.05 vs. corresponding vehicle). retinyl ester concentrations. The other is that hyperoxia exposure leads to inflammation, which reduces synthesis of retinol transport proteins (retinol-binding protein and transthyretin), which results in less retinyl esters being transported to the lung from the intestines (40) . Hyperoxia exposure increases the production of ROS such as superoxide anion, hydroxyl radical, and hydrogen peroxide, which mediate hyperoxia-induced impaired alveolar development and lung function (21, 22) . Hyperoxia-mediated ROS production has been directly linked to the oxidation of DNA, proteins, and lipids, which may impair alveolar septation directly or indirectly by cellular responses induced through generation of secondary metabolic reactive species (9, 24) . Increased DNA and protein oxidation correlate with the development of BPD in preterm infants (28) . The hyperoxia-induced increases in DNA and protein oxidation and the attenuation of these changes with VARA indicate a possible antioxidant mechanism of retinoids. It is possible that retinoids scavenge ROS via electron transfer and prevent DNA and protein oxidation (24) . VARA-induced attenuation of oxidant injury may also be mediated via modulation of Nrf2 (104).
Hyperoxia may increase ROS and initiate lung inflammation via multiple mechanisms, including activation of transcription factors, signal transduction, and gene expression of proinflammatory mediators (42) . The development of BPD in preterm infants is associated with increases in proinflammatory cytokines such as IFN-␥, TNF-␣, IL-6, IL-8 (analogous to mouse MIP-2␣; Cxcl2), IL-10, and IL-1␤ (4). Animal studies indicate that blocking inflammation improves alveolar development and DNA oxidation (7, 19) . Bry and Lappalainen (12) found that inflammation prevents expression of RA-binding proteins (e.g., CRABP-I) and receptors (e.g., RAR-␥2), which may lead to reduced alveolar septation. Hogmalm et al. demonstrated that CXCR2 (MIP-2␣, keratinocyte-derived chemokine receptor) null mice expressing IL-1␤ had improved lung development compared with wild-type mice expressing IL-1␤ (25) . Our data suggest that hyperoxia increases many proinflammatory mediators in newborn mice, which are attenuated by VARA. However, while MIP-2␣ and IFN-␥ had concordant changes in mRNA and protein, we observed that changes in IL-1␤ and TNF-␣ protein did not correlate with changes in mRNA. It is possible that posttranscriptional changes in pro- , and Nrf2 (E) were analyzed by ELISA, and myeloperoxidase (MPO, F) was analyzed by a colorimetric activity assay in lung homogenates of 14-day mouse pups exposed from birth to air or hyperoxia, in combination with either vehicle or VARA (n ϭ 6 mice/group; mean Ϯ SE; *P Ͻ 0.05 vs. corresponding air; #P Ͻ 0.05 vs. corresponding vehicle).
tein synthesis or stability may be involved with, and possibly regulated by, retinoids (29) . Alveolar development is coordinated by multiple paracrine interactions between the fibroblastic, epithelial, and microvascular lung components, all of which also interact with the extracellular matrix (11) . Our study indicates that hyperoxia modulates many growth factors that are important in alveolar development and that VARA influences many of these factors such as angiopoietin-2, epiregulin, FGF-1, frizzled homolog 5, HIF-1␣, MMP-2, and MMP-9. Some of the alterations induced by hyperoxia such as increases in MMP-9, Shh, and LOX and decreases in MMP-2 may contribute to impaired alveolar development (14, 30) . Of the growth factors known to be involved in lung development, we noted that hyperoxia-induced increases in PDGF-A mRNA were not associated with corresponding increases in PDGF protein and that hyperoxiainduced decreases in VEGF mRNA were associated with corresponding increases in VEGF protein. It is possible that alterations in protein stability induced by hyperoxia are responsible for these phenomena (the consequences of which need to be further evaluated) and demonstrate the importance of not relying solely on gene expression data. It is likely that many growth factors involved in alveolarization are regulated by retinoids at different postnatal time points (10) . Tenascin C was increased during hyperoxia at 14 days but not at the earlier time point of 7 days, and VARA did not alter tenascin C concentrations. Tenascin C is known to be involved in an autocrine loop in inflammation (23) , and it is possible that the hyperoxia-induced increases in this molecule modulate lung inflammation.
In summary, our study shows that the VARA combination improves alveolar development and lung function in newborn PDGF-A/␤-tubulin and tenascin C/␤-tubulin ratios in Western blots quantitated by densitometry in lung homogenates of 14-day mouse pups exposed from birth to air or hyperoxia in combination with either vehicle or VARA (n ϭ 6 mice/group; mean Ϯ SE; *P Ͻ 0.05 vs. corresponding air). C: representative Western blots of lung homogenates for PDGF-A and tenascin C from 14-day mouse pups exposed from birth to air or hyperoxia in combination with either vehicle or VARA.
mice exposed to hyperoxia during the critical period of maximal alveolar formation. This improvement in alveolar development and lung function is associated with reductions in DNA damage and protein oxidation accompanied with reductions in nuclear Nrf2 and beneficial changes in multiple pathways, including inflammation and growth factors.
